Expression and role of the immune checkpoint regulator PD-L1 in the tumor-stroma interplay of pancreatic ductal adenocarcinoma

INTRODUCTION: Immune checkpoint inhibitors (ICI), e.g., targeting programmed cell death protein 1-ligand 1 (PD-L1) or its receptor PD-1, have markedly improved the therapy of many cancers but so far failed in pancreatic ductal adenocarcinoma (PDAC). Macrophages represent one of the most abundant imm...

Descripción completa

Detalles Bibliográficos
Autores principales: Daunke, Tina, Beckinger, Silje, Rahn, Sascha, Krüger, Sandra, Heckl, Steffen, Schäfer, Heiner, Wesch, Daniela, Pilarsky, Christian, Eckstein, Markus, Hartmann, Arndt, Röcken, Christoph, Wandmacher, Anna Maxi, Sebens, Susanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337136/
https://www.ncbi.nlm.nih.gov/pubmed/37449210
http://dx.doi.org/10.3389/fimmu.2023.1157397

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337136/
https://www.ncbi.nlm.nih.gov/pubmed/37449210
http://dx.doi.org/10.3389/fimmu.2023.1157397

Ejemplares similares